Kestra Medical Technologies (KMTS) Net Cash Flow (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Net Cash Flow data on file, last reported at -$191.6 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 204.57% year-over-year to -$191.6 million in Q2 2026; TTM through Apr 2026 was -$137.9 million, a 160.12% decrease from a year earlier, with the FY2026 full-year figure at -$137.9 million, down 160.12% from the prior year.
• Net Cash Flow for Q2 2026 stood at -$191.6 million, down from $115.9 million in the prior quarter.
• Over the last five years, Net Cash Flow for KMTS reached as high as $183.2 million in Q2 2025 and fell as low as -$191.6 million in Q2 2026.
• Historically, Net Cash Flow has averaged $9.4 million across 3 years, with a median of -$22.6 million in 2025.
• Across the five-year window, Net Cash Flow surged 2766.9% in 2025 and plunged 204.57% in 2026, its largest moves.
• Year by year, Net Cash Flow stood at -$23.1 million in 2024, then fell by 11.88% to -$25.8 million in 2025, then slumped by 642.97% to -$191.6 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$191.6 million in Q2 2026, $115.9 million in Q1 2026, and -$25.8 million in Q4 2025.